1 completed, 1 recruiting. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Recruiting 1 |
Follow Hormone Receptor Positive Malignant Neoplasm of Breast: new trials by email Literature Review of Hormone Receptor Positive Malignant Neoplasm of Breast trials Research Report on Hormone Receptor Positive Malignant Neoplasm of Breast
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Revaree Plus in People With Breast Cancer Revaree Plus - Breast Cancer, Stage 0 Breast Cancer | Phase 4 | Recruiting | Memorial Sloan Kettering Cancer Center | 60 | 2025-06-20 | 2026-02-06 |
| Patient Preference for Everolimus in Combination With Exemestane or Capecitabine in Combination With Bevacizumab Bevacizumab, Capecitabine, Everolimus - Breast Cancer Recurrent, HER2/Neu-negative Carcinoma of Breast | Phase 4 | Completed | iOMEDICO AG | 85 | 2014-08-01 | 2017-11-13 |
Breast Neoplasms (2) · Breast Carcinoma In Situ (1) · Neoplasm Metastasis (1)
Breast Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Carcinoma (1) · Carcinoma in Situ (1) · Neoplasms by Histologic Type (1) · Neoplasms, Glandular and Epithelial (1) · Neoplastic Processes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Bevacizumab (1) · Capecitabine (1) · Everolimus (1) · exemestane (1)
Memorial Sloan Kettering Cancer Center (1) · iOMEDICO AG (1)
Germany (1) · United States (1)
Shari Goldfarb, MD (1) · Thomas Decker, MD (1)